Status asthmaticus
MONDO:0004766An acute exacerbation of asthma, characterized by inadequate response to initial bronchodilators.
27 clinical trials for this condition and its sub-types, 26 tagged with Status asthmaticus itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →Part of
-
Can a structured care plan keep asthma patients out of the hospital?
Disease control Not yet recruitingResearchers are studying whether a structured care plan called the Indian Asthma Care Bundle (I-ACB) helps adults and children in India manage asthma after a severe attack. The study follows patients discharged from the hospital and compares those who receive the bundle with thos…
Sponsor: Ahmedabad University • Aim: Disease control
Last updated Sep 13, 2026 00:00 UTC
-
Can a higher magnesium dose tame severe asthma attacks?
Disease control Not yet recruitingThis trial tests whether a high-dose continuous infusion of magnesium sulfate can improve outcomes for adults with severe asthma attacks in the emergency department. Participants are randomly assigned to receive either the high-dose infusion or the standard dose. Researchers meas…
Sponsor: Thammasat University • Aim: Disease control
Last updated Sep 02, 2026 00:00 UTC
-
Could a common anesthetic ease severe asthma in kids?
Symptom relief Not yet recruitingThis Phase 2 trial tests whether inhaled ketamine can improve breathing in children aged 1 to 13 with severe asthma attacks that do not respond to standard treatments. Participants receive either nebulized ketamine or a placebo every six hours for 24 hours, alongside usual care. …
Phase 2 • Sponsor: Sultan Qaboos University • Aim: Symptom relief
Last updated Jul 29, 2026 00:00 UTC
-
Could an arthritis drug stop asthma attacks in their tracks?
Symptom relief Not yet recruitingThis pilot study tests whether anakinra, a drug that reduces inflammation, can help people with moderate asthma attacks. 60 adults at high risk for asthma attacks will either receive anakinra or a placebo at home when they feel an attack starting. The study will check if this app…
Phase 1 • Sponsor: University of North Carolina, Chapel Hill • Aim: Symptom relief
Last updated Jul 17, 2026 00:00 UTC